Empery Asset Management, LP 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-08 10:26 am Sale | 2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Empery Asset Management, LP | 151,654 2.650% | -54,969 (-26.60%) | Filing |
| 2023-01-13 08:02 am Purchase | 2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Empery Asset Management, LP | 206,623 5.120% | 206,623 (New Position) | Filing |